Pharma-Bio Serv, Inc.
PBSV
Rank in Stocks
#28322
Pharma-Bio Serv, Inc. functions as a specialized consulting firm, providing... Pharma-Bio Serv, Inc. functions as a specialized consulting firm, providing services focused on regulatory compliance and the transfer of technology. The company offers its compliance expertise to a diverse range of clients, including those in the pharmaceutical, chemical, biotechnology, medical device, cosmetic, and food industries, as well as related product companies. Its operational reach extends across Puerto Rico, the United States, Europe, and Brazil. The firm's technical advisory offerings encompass vital areas such as regulatory adherence, system validation, technology migration, engineering solutions, comprehensive project management, and ongoing process support. Established in 1993, Pharma-Bio Serv maintains its corporate headquarters in Dorado, Puerto Rico.
Share Price
$0.5
Last synced: 2026-11-09
Market Cap
$11.45M
Change (1 day)
19.05%
Change (1 year)
-7.41%
Country
Stock data: Financial Modeling PrepΒ·Updated Β·Not investment adviceΒ·How we calculate this
Trade Pharma-Bio Serv, Inc. (PBSV)
Category
Industrials
Operating Margin for Pharma-Bio Serv, Inc. (PBSV)
Operating Margin as of November 2026 TTM: -1.63%
According to Pharma-Bio Serv, Inc.'s latest financial reports, its current operating margin (TTM) is -1.63%. At the end of 2025 the company had an operating margin of -7.08%.
Operating Margin history for Pharma-Bio Serv, Inc. from 2005 to 2026
Operating Margin at the end of each year
| Year | Operating Margin | Change |
|---|---|---|
| 2026 (TTM) | -1.63% | -76.98% |
| 2025 | -7.08% | -47.71% |
| 2024 | -13.54% | -305.78% |
| 2023 | 6.58% | 8.58% |
| 2022 | 6.06% | -131.63% |
| 2021 | -19.16% | -285.66% |
| 2020 | 10.32% | 18.62% |
| 2019 | 8.70% | 42.39% |
| 2018 | 6.11% | -166.78% |
| 2017 | -9.15% | 1,846.81% |
| 2016 | -0.47% | -106.17% |
| 2015 | 7.62% | -26.66% |
| 2014 | 10.39% | -43.41% |
| 2013 | 18.36% | -6.42% |
| 2012 | 19.62% | 13.28% |
| 2011 | 17.32% | 221.93% |
| 2010 | 5.38% | -32.50% |
| 2009 | 7.97% | -54.35% |
| 2008 | 17.46% | -22.43% |
| 2007 | 22.51% | -17.61% |
| 2006 | 27.32% | -113.66% |
| 2005 | -200.00% | 0.00% |
Operating Margin for similar companies or competitors
| Company | Operating Margin | Operating Margin Difference | Country |
|---|---|---|---|
| 14.99% | -109.20% |
CH
|
|
| 18.83% | -111.55% |
US
|
|
| 14.34% | -108.80% |
FR
|
|
| 17.26% | -110.59% |
US
|
|
| 33.27% | -120.41% |
JP
|
What is a company's Operating Margin?
The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.
Questions about Pharma-Bio Serv, Inc.'s operating margin
What is Pharma-Bio Serv, Inc.'s operating margin?
Pharma-Bio Serv, Inc.'s operating margin is -1.63%, as of Nov 2026.
What was Pharma-Bio Serv, Inc.'s operating margin in 2025?
In 2025, Pharma-Bio Serv, Inc.'s operating margin was -7.08%, compared with -13.54% in 2024.
How has Pharma-Bio Serv, Inc.'s operating margin changed since 2020?
From 2020 to 2025, Pharma-Bio Serv, Inc.'s operating margin was highest in 2020 (10.32%) and lowest in 2021 (-19.16%).
How does Pharma-Bio Serv, Inc.'s operating margin compare with similar companies?
Pharma-Bio Serv, Inc.'s operating margin (-1.63%) is lower than that of all 5 similar companies listed above. The highest among them is BayCurrent, Inc, with 33.27%.